Sr. Manager Method Validation @ (October 2018 - September 2019)
Associate Director, QC Conformance @ (October 2017 - October 2018)
Sr. Manager, QC Virology and Cell Characteristics @ (March 2013 - October 2017)
Manager and Sr. Scientist, Analytical Development Lead, (Bioassay and Immunoassay Development) @ (December 2006 - March 2013)
Scientist @ (October 2006 - December 2006)
Group Leader and Principal Scientist, Antibody Discovery Group @ (November 2003 - December 2006)
Research Scientist @ Pfizer (formerly SUGEN, Inc.) (January 2000 - July 2003)
Bob To Education
Purdue University
Ph.D. (Biological Sciences)
University of California, San Francisco (UCSF)
Postdoctoral Fellow (Cardiovascular Research Institute (CVRI))
University of California, Davis
BS (Biochemistry)
Bob To Skills
Analytical Method Validation
Analytical Methods Development
Antibodies
Cancer Biology
Cell Based Assays
Cell Biology
Cell Culture
Cell Therapy
Chemistry, Manufacturing, and Controls (CMC)
Compliance Management
Continuous Improvement
Cross-functional Coordination
Cross-functional Team Leadership
ELISA
Good Manufacturing Practice (GMP)
Molecular Biology
Partner Relationship Management
Project Oversight
Protein Kinases
Quality Auditing
Quality Control
Raw Materials
Regulatory Submissions
Technology Transfer
Testing
Western Blotting
Bob To Summary
Bob To, based in California, United States, is currently a Director of Clinical QC at Disc Medicine. Bob To brings experience from previous roles at Allogene Therapeutics. Bob To holds a Ph.D. in Biological Sciences @ Purdue University. With a robust skill set that includes Analytical Method Validation, Analytical Methods Development, Antibodies, Cancer Biology, Cell Based Assays and more. Bob To has 1 emails on RocketReach.
Looking for a different Bob To?
Find contact details for 700 million professionals.